Peptic Ulcer Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The peptic ulcer market size has grown steadily in recent years. It will grow from $4.1 billion in 2024 to $4.24 billion in 2025 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to increased prevalence of helicobacter pylori infection, rising use of nonsteroidal anti-inflammatory drugs (NSAIDs), changing lifestyles and dietary habits, awareness campaigns and educational initiatives, focus on stress management.

The peptic ulcer market size is expected to see steady growth in the next few years. It will grow to $4.91 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to emerging therapies and treatment modalities, increasing geriatric population, integration of precision medicine, preventive measures and health promotion, continued research and clinical trials. Major trends in the forecast period include digital health solutions, advancements in treatment modalities, increasing prevalence of helicobacter pylori infection, integration of diagnostic imaging technologies, increasing use of combination therapies.

The rising incidence of obesity is anticipated to drive the growth of the peptic ulcer market in the future. Obesity is a medical condition marked by an excessive accumulation of body fat, typically defined as having a body mass index (BMI) of 30 or higher. It can arise from a combination of genetic, environmental, and lifestyle factors, including poor dietary habits and insufficient physical activity. Obesity leads to an overproduction of stomach acid, compromises the protective mucosal lining of the stomach, and contributes to the development of peptic ulcers. Additionally, excess weight appears to increase inflammation in the gut, which can further facilitate the emergence of peptic ulcers. For example, in September 2024, the Centers for Disease Control and Prevention, a U.S.-based public health agency, reported that between August 2021 and August 2023, the prevalence of obesity among adults was 40.3%, with rates of 39.2% in men and 41.3% in women. Thus, the increasing prevalence of obesity is driving the expansion of the peptic ulcer market.

The escalating rates of smoking are expected to fuel the peptic ulcer market's growth in the foreseeable future. Smoking, the inhalation of vapors from burning plant-based products such as tobacco or marijuana, is a well-established contributor to peptic ulcer disease. Smoking harms the stomach and duodenal linings, reduces blood supply to the stomach, and increases stomach acid production, elevating the incidence of peptic ulcers. For example, data from Quit Victoria in June 2023 highlighted a threefold increase in current cigarette smoking among 14-17-year-olds over four years, reaching 6.7% in 2022. Consequently, the rising smoking rates serve as a driving factor for the peptic ulcer market.

Companies in the peptic ulcer market are focusing on developing innovative products and solutions, obtaining approval from federal agencies to secure a competitive advantage. The development of drugs is essential for managing and treating peptic ulcers, as it helps with symptom management, healing, preventing complications, and addressing the underlying issues. For example, in April 2023, Akums Drugs and Pharmaceutical Ltd., a pharmaceutical formulations and active pharmaceutical ingredients (APIs) company based in India, launched its new formulation, the Combikit, which combines Amoxicillin, Clarithromycin, and Esomeprazole. This Combikit has been approved by the Central Drugs Standard Control Organisation (CDSCO) for the treatment of duodenal ulcers associated with Helicobacter pylori (H. pylori) and for the eradication of H. pylori in patients with either active or healed peptic ulcers. The therapy targeting H. pylori has shown effectiveness in reducing the risk of ulcer recurrence, providing significant advantages to patients. H. pylori is a common infection in India and is linked to the development of gastritis and peptic ulcers.

In July 2022, Juvisé Pharmaceuticals, a France-based pharmaceutical company, acquired the global commercial rights to Pylera from AbbVie Inc. for $408 million (€400 million). Pylera, an antimicrobial tri-therapy, targets peptic ulcers caused by Helicobacter pylori (H. pylori) infection. This acquisition is expected to facilitate Juvisé Pharmaceuticals' expansion of its gastro-intestinal medicine product portfolio, serving as a strategic addition for geographic expansion. AbbVie Inc., a U.S.-based pharmaceutical company, specializes in providing various medications for diverse conditions, including peptic ulcers.

Major companies operating in the peptic ulcer market report are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.

North America was the largest region in the peptic ulcer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the peptic ulcer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The peptic ulcer market consists of revenues earned by entities by providing treatment services related to peptic ulcer such as surgeries, endoscopy, blood tests, and physical exams. The market value includes the value of related goods sold by the service provider or included within the service offering. The peptic ulcer market also includes sales of acid blockers, cytoprotective agents, bismuth subsalicylate, and mastic powder. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

An open sore or raw area in the stomach lining or intestine is known as a peptic ulcer. It is primarily a result of the erosion of the protective lining of the stomach or the upper part of the small intestine, known as the duodenum. Common symptoms of peptic ulcers include upper abdominal pain or discomfort and symptoms of acid reflux, such as heartburn, sometimes accompanied by nausea.

The primary disease indications consist of gastritis, gastric ulcers, duodenal ulcers, and gastroesophageal reflux disease (GERD). Gastritis is a medical condition characterized by inflammation, irritation, or erosion of the stomach lining. The typical approach to treating gastritis involves medications such as proton pump inhibitors and lifestyle adjustments. The drugs utilized include proton pump inhibitors (PPI), H2 antagonists, antibiotics, and other pharmaceuticals, which are distributed through various channels such as hospital pharmacies, private clinics, drug stores, retail pharmacies, and e-commerce.

The peptic ulcer market research report is one of a series of new reports that provides peptic ulcer market statistics, including peptic ulcer industry global market size, regional shares, competitors with a peptic ulcer market share, detailed peptic ulcer market segments, market trends and opportunities, and any further data you may need to thrive in the peptic ulcer industry. This peptic ulcer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.